Cited by 145Gastrointestinal motility and disordersDiabetes Treatment and ManagementNeuropeptides and Animal Physiology

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

Open access
Schirra, J, Houck, P, Wank, U, Arnold, R, Göke, B, Katschinski, M·2000·Gut

Abstract

BACKGROUND: Glucagon-like peptide-1(7-36)amide (GLP-1) is a gut hormone released postprandially. Synthetic GLP-1 strongly inhibits gastric emptying in healthy subjects and in patients with diabetes mellitus. AIMS: To investigate the effects of GLP-1 on antro-pyloro-duodenal motility in humans. METHODS: Eleven healthy male volunteers were studied on two separate days. On the interdigestive study day, a basal period was followed by a 60 minute period of saline infusion and two further 60 minute periods of intravenous infusion of GLP-1 0.4 and 1.2 pmol/kg/min to achieve postprandial and supraphysiological plasma levels, respectively. On the postprandial study day, the same infusions were coadministered with intraduodenal lipid perfusion at 2.5 ml/min (2.5 kcal/min) followed by another 60 minutes of recording after cessation of GLP-1. Antro-pyloro-duodenal motility was measured by perfusion manometry. RESULTS: GLP-1 significantly inhibited the number and amplitudes of antral and duodenal contractions in the interdigestive state and after administration of duodenal lipid. It abolished interdigestive antral wave propagation. In the interdigestive state, GLP-1 dose dependently increased pyloric tone and significantly stimulated isolated pyloric pressure waves (IPPW). Pyloric tone increased with duodenal lipid, and this was further enhanced by GLP-1. GLP-1 transiently restored the initial IPPW response to duodenal lipid which had declined with lipid perfusion. Plasma levels of pancreatic polypeptide were dose dependently diminished by GLP-1 with and without duodenal lipid. CONCLUSIONS: GLP-1 inhibited antro-duodenal contractility and stimulated the tonic and phasic motility of the pylorus. These effects probably mediate delayed gastric emptying. Inhibition of efferent vagal activity may be an important mechanism. As postprandial plasma levels of GLP-1 are sufficient to appreciably affect motility, we believe that endogenous GLP-1 is a physiological regulator of motor activity in the antro-pyloro-duodenal region.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.46.5.622

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In healthy subjects, this GLP-1 dose inhibited antro-duodenal contractility, increased pyloric tone, and increased fasting gastric volumes.

    “In healthy subjects, this dose inhibited antro-duodenal contractility, increased pyloric tone, and also increased fasting gastric volumes (1, 40).”

    From Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans (2008) · cites this paper as [40]

    The Abstract and Discussion (page not available) report inhibited antroduodenal contractions and increased pyloric tone in healthy volunteers. The paper did not measure fasting gastric volume; its Discussion mentions only preliminary evidence from another study of proximal-stomach relaxation at the same doses, which does not establish the claimed increase in fasting volume. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Schirra J, Leicht P, Hildebrand P, et al. Mechanism of the antidiabetic action of subcutaneous GLP-1 in NIDDM. J Endocrinol 1998;156:177-86.
  2. Eliasson B, Björnsson E, Urbanavicus V, et al. Hyperinsuli- naemia impairs gastrointestinal motility and slows carbohy- drate absorption. Diabetologia 1995;38:79-85.

Cited by

Sorted by citations

Authors
Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M.
Affiliations
Philipps University of Marburg (DE)
Corresponding author
Schirra, J
Venue
Gut
Publisher
BMJ
Published
2000-05-01
Volume
46
Issue
5
Pages
622-631
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2097325055
Cited by
145
References
58
Citations by year
2026: 8 · 2025: 9 · 2024: 8 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 6 · 2012: 4
FWCI
5.69
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
glucagon-like peptide-1(7-36)amide, antral contractions, pancreatic polypeptide, gastric emptying, vagal efferent activity, gastrointestinal hormones
MeSH terms
Adult, Duodenum, Gastric Emptying, Gastrointestinal Motility, Glucagon, Humans, Lipids, Male, Manometry, Peptide Fragments, Pressure, Protein Precursors, Pyloric Antrum, Time Factors, Postprandial Period, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review